Kissei Pharmaceutical Co (TSE:4547) EBIT per Share : 円319.49 (TTM As of Dec. 2023)

View and export this data going back to 1988. Start your Free Trial

What is Kissei Pharmaceutical Co EBIT per Share?

Kissei Pharmaceutical Co's EBIT per Share for the three months ended in Dec. 2023 was 円80.17. Its EBIT per Share for the trailing twelve months (TTM) ended in Dec. 2023 was 円319.49.

During the past 3 years, the average EBIT per Share Growth Rate was 40.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.

The historical rank and industry rank for Kissei Pharmaceutical Co's EBIT per Share or its related term are showing as below:

TSE:4547' s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: -46.1 Med: 7.5 Max: 49.4
Current: 40.1

During the past 13 years, the highest 3-Year average EBIT per Share Growth Rate of Kissei Pharmaceutical Co was 49.40% per year. The lowest was -46.10% per year. And the median was 7.50% per year.

TSE:4547's 3-Year EBIT Growth Rate is ranked better than
83.82% of 859 companies
in the Drug Manufacturers industry
Industry Median: 7.5 vs TSE:4547: 40.10

Kissei Pharmaceutical Co's EBIT for the three months ended in Dec. 2023 was 円3,602 Mil.

Kissei Pharmaceutical Co EBIT per Share Historical Data

The historical data trend for Kissei Pharmaceutical Co's EBIT per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kissei Pharmaceutical Co EBIT per Share Chart

Kissei Pharmaceutical Co Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

EBIT per Share

Get a 7-Day Free Trial

99.60

160.70

358.45

297.08

319.68

Kissei Pharmaceutical Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
EBIT per Share	Get a 7-Day Free Trial															101.81	94.59	68.92	80.17	75.81

Kissei Pharmaceutical Co EBIT per Share Calculation

EBIT per Share is the amount of Earnings Before Interest and Taxes (EBIT) per outstanding share of the company's stock.

Earnings Before Interest and Taxes (EBIT) is what the company earns before it expenses interest and taxes.

Kissei Pharmaceutical Co's EBIT per Share for the fiscal year that ended in Mar. 2024 is calculated as

	EBIT per Share		(A: Mar. 2024 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	14467	/	45.254
=	319.68

Kissei Pharmaceutical Co's EBIT per Share for the quarter that ended in Dec. 2023 is calculated as

	EBIT per Share		(Q: Dec. 2023 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	3602	/	44.929
=	80.17

EBIT per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was 円319.49

Kissei Pharmaceutical Co (TSE:4547) EBIT per Share Explanation

EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.

Kissei Pharmaceutical Co EBIT per Share Related Terms

Thank you for viewing the detailed overview of Kissei Pharmaceutical Co's EBIT per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Kissei Pharmaceutical Co (TSE:4547) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Kissei Pharmaceutical Co Ltd (TSE:4547) » Definitions » EBIT per Share

Comparable Companies

Traded in Other Exchanges

KSPHF:USA

Address

19-48, Yoshino, Matsumoto City, Nagano, JPN, 399-8710

Website

http://www.kissei.co.jp

Kissei Pharmaceutical Co Ltd is a specialty and generic drug manufacturing company. Pharmaceuticals is the company's reportable segment. The company's operations span across the globe, while the vast majority of revenue is generated in Japan, followed by Europe. Kissei operates a variety of subsidiaries. The company considers merger and acquisition investment as a potential component of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities.

Kissei Pharmaceutical Co (TSE:4547) Headlines

No Headlines